Immuron Limited (IMRN)

NASDAQ: IMRN · Real-Time Price · USD

1.900

-0.120 (-5.94%)

At close: Oct 31, 2025, 4:00 PM EDT

1.820

-0.080 (-4.21%)

After-hours: Oct 31, 2025, 6:38 PM EDT

Revenue by Product

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2003 - 2019
Hyper-immune Products	4.90M	Log In	Log In	Log In	Log In	Upgrade
Hyper-immune Products Growth	171.67%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2003 - 2019
Australia	3.75M	Log In	Log In	Log In	Log In	Upgrade
Australia Growth	222.77%	Log In	Log In	Log In	Log In	Upgrade
United States	1.08M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	67.33%	Log In	Log In	Log In	Log In	Upgrade
Canada	80.89K	Log In	Log In	Log In	Log In	Upgrade
Canada Growth	6635.05%	Log In	Log In	Log In	Log In	Upgrade